UBS Group
AUXL

UBS Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

UBS Group’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-124,741
Closed -$4.29M – 10096
2014
Q4 		$4.29M Buy
+124,741
New +$4.07M ﹤0.01% 2234

Other funds holding AUXL

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

UBS Group's AUXL Position: Q1 2015 in Review

UBS Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 124,741 shares — an estimated $4.29M sold.

UBS Group first reported a position in AUXL in Q4 2014 and held it in 1 quarter. The position peaked at $4.29M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • UBS Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • UBS Group sold 124,741 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.29M.
  • UBS Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q4 2014 and held it in 1 quarter.
  • UBS Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $4.29M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on UBS Group's 13F filing for Q1 2015, filed 14 May 2015.